Muna Therapeutics ApS is a Danish APS based in Frederiksberg, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 2020, the company has 18 employees and reported revenue of -60,6 mio. kr. in its latest annual filing.
Selskabet tegnes af bestyrelsesformanden i forening med et bestyrelsesmedlem, eller af bestyrelsesformanden
i forening med en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at forske i, udvikle, producere og sælge bioteknologiske produkter
og medicinalprodukter samt anden virksomhed, der efter ledelsens skøn er forbundet dermed.
In its most recent annual report (2025), Muna Therapeutics ApS reported a gross profit of -60,6 mio. kr.. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of 125,7 mio. kr..
At the end of 2025, current assets covered short-term debt 1.5 times.
Frequently asked questions
What is the CVR number of Muna Therapeutics ApS?
Muna Therapeutics ApS is registered with CVR / Virk under CVR 41142871.
What is the revenue of Muna Therapeutics ApS?
Muna Therapeutics ApS reported revenue of -60,6 mio. kr. in 2025.
How many employees does Muna Therapeutics ApS have?
Muna Therapeutics ApS employs 18 people as of the latest annual report.
Who is the CEO of Muna Therapeutics ApS?
Michel Marcel A. Detheux is the CEO of Muna Therapeutics ApS, in role since 2026.
Who is the chairman of Muna Therapeutics ApS?
Donald William Nicholson chairs the board of Muna Therapeutics ApS, in role since 2021.
Where is Muna Therapeutics ApS headquartered?
Muna Therapeutics ApS's registered address is Nordre Fasanvej 215.
